Tel Aviv Stock Exchange (TASE) Investment Guide for Foreign Investors

The Tel Aviv Stock Exchange, established in 1953, has evolved into a sophisticated financial marketplace that serves as Israel’s primary platform for trading publicly traded stock companies. As of 2026, TASE operates as a fully electronic exchange with trading hours from 9:00 AM to 5:25 PM Israel Standard Time, Sunday through Thursday, reflecting Israel’s business week.

TASE features several indices that track market performance, with the TA-35 Index serving as the benchmark for the 35 largest companies by market capitalization and liquidity. The TA-125 Index broadens this perspective to include 125 leading companies across various sectors. Understanding these indices helps foreign investors gauge overall market sentiment and sector-specific trends.

The exchange operates multiple trading platforms including the main equity market, corporate bonds, government bonds, exchange-traded funds (ETFs), and derivatives. For foreign investors, the equity market typically presents the most accessible entry point, though diversification across asset classes remains an option for sophisticated investors.

TASE has implemented international best practices in market regulation, transparency, and investor protection. The exchange adheres to standards comparable to major public stock exchanges globally, including real-time disclosure requirements, strict listing standards, and robust surveillance systems to prevent market manipulation.

One distinctive feature of TASE is the prevalence of dual-listed companies that trade simultaneously on both TASE and international exchanges such as NASDAQ or the New York Stock Exchange. This creates arbitrage opportunities and provides foreign investors with multiple access points to the same underlying securities.

For international investors wondering how foreigners can invest in the Tel Aviv Stock Exchange, the answer lies primarily in selecting the right access channel. Foreign investors have three main pathways to purchase Israeli stocks: international brokers with TASE access, Israeli brokerage firms accepting foreign clients, and specialized investment platforms focused on emerging markets.

Major international brokerage platforms have expanded their offerings to include TASE-listed securities. Interactive Brokers, for instance, provides direct access to TASE through its global trading platform, allowing investors to trade Israeli stocks alongside securities from over 135 markets worldwide. Similarly, platforms like Saxo Bank and eToro offer varying degrees of access to publicly traded stock companies on TASE, though the breadth of available securities may differ from platform to platform.

Israeli brokerage firms such as Meitav Dash, Psagot Investment House, and IBI Investment House welcome foreign clients and provide comprehensive access to all TASE-listed securities. These local brokers often offer deeper market insights, research reports in English, and dedicated support for navigating Israeli market peculiarities. However, they typically require more extensive documentation during the account opening process.

When selecting a broker, foreign investors should evaluate several critical factors: commission structures for TASE trades, currency conversion fees (as TASE trades primarily in New Israeli Shekels), availability of research and analysis tools, quality of customer support in English, and the broker’s regulatory standing both internationally and with Israeli authorities.

Some brokers offer nominee accounts where securities are held in the broker’s name on behalf of the client, while others facilitate direct registration with the Israel Securities Authority. Each approach has implications for voting rights, dividend collection, and tax documentation, making it essential to understand the account structure before committing capital.

Technology has simplified access considerably by 2026, with most platforms offering mobile trading applications, real-time market data, and integrated tax reporting. Nevertheless, foreign investors should verify that their chosen platform provides adequate TASE market depth, as some international brokers offer only the most liquid Israeli securities rather than the full universe of publicly traded stock companies.

Understanding what are the requirements to buy Israeli stocks as a non-resident is crucial before initiating the investment process. The account setup procedure involves multiple steps and documentation requirements designed to comply with both Israeli regulations and international anti-money laundering standards.

Foreign investors must first provide comprehensive identity verification, typically including a valid passport, proof of address (utility bill or bank statement dated within the last three months), and in some cases, a notarized copy of identification documents. Some Israeli brokers may require apostille certification for documents originating from certain jurisdictions.

Bank of Israel regulations require foreign investors to establish a relationship with an Israeli financial institution or work through a licensed broker who maintains such relationships. This doesn’t necessarily mean opening a full Israeli bank account, though some investors choose this route for convenience. Many brokers facilitate the necessary banking connections through their existing institutional relationships.

The Israel Securities Authority (ISA) mandates that all investors, domestic and foreign, complete a suitability questionnaire assessing investment knowledge, experience, risk tolerance, and financial capacity. This assessment determines which financial products investors can access, with more complex derivatives and leveraged instruments requiring demonstrated sophistication.

Foreign investors must also provide tax identification information, including their Tax Identification Number (TIN) from their country of residence and, for U.S. citizens or residents, a completed W-8BEN or W-9 form. This documentation enables proper tax withholding and facilitates compliance with international tax treaties that may reduce withholding rates on dividends and interest.

Currency considerations form another layer of the setup process. While TASE operates primarily in New Israeli Shekels (ILS), most international brokers allow funding in major currencies like USD, EUR, or GBP, handling conversion automatically. However, investors should understand the exchange rate mechanisms, conversion fees, and timing of currency transactions to avoid unexpected costs.

Regulatory compliance extends to ongoing reporting requirements. Foreign investors holding significant positions (typically above 5% of a company’s shares) must file disclosure reports with the ISA. Even below this threshold, certain corporate actions and voting rights may require additional documentation for foreign shareholders.

The typical account approval timeline ranges from 3 to 10 business days for international brokers and potentially longer for Israeli brokerage firms, depending on documentation completeness and the investor’s jurisdiction. Countries with established regulatory cooperation agreements with Israel generally experience faster processing.

The Israel Securities Authority serves as the primary regulatory body overseeing all securities activities within Israel, including the participation of foreign investors in publicly traded stock companies. Understanding ISA’s regulatory framework helps investors navigate compliance requirements and appreciate the investor protections in place.

Established in 1968, the ISA operates with a mandate similar to the U.S. Securities and Exchange Commission or the UK’s Financial Conduct Authority. Its responsibilities include supervising public stock exchanges, licensing market participants, enforcing securities laws, and protecting investors from fraud and manipulation.

For foreign investors, ISA registration occurs indirectly through their broker or financial intermediary. Licensed brokers maintain registration with the ISA and assume responsibility for their clients’ compliance with Israeli securities regulations. This intermediated model means individual foreign investors don’t typically file directly with the ISA unless they cross significant ownership thresholds.

The ISA has implemented comprehensive disclosure requirements for all publicly traded stock companies, mandating quarterly financial reports, immediate disclosure of material events, and annual audited financial statements prepared according to International Financial Reporting Standards (IFRS) or U.S. Generally Accepted Accounting Principles (GAAP). These reports must be published in Hebrew, though many larger companies voluntarily provide English translations.

In 2026, the ISA has enhanced its focus on cybersecurity, requiring listed companies to maintain robust data protection measures and disclose cyber incidents that could materially affect their business. For investors, this regulatory attention provides additional assurance about the integrity of financial information and operational resilience of portfolio companies.

The ISA also regulates stock exchange IPO processes, ensuring that companies going public provide comprehensive prospectuses, maintain adequate public float, and meet minimum financial and governance standards. These listing requirements help filter out less-established companies, though they also mean that early-stage startups typically list on international exchanges before potentially dual-listing on TASE.

Market surveillance represents another critical ISA function. The authority employs sophisticated monitoring systems to detect insider trading, price manipulation, and other market abuses. Foreign investors benefit from these protections, which help maintain market integrity and fair pricing.

Compliance violations can result in significant penalties, including fines, trading suspensions, and criminal prosecution in severe cases. However, foreign investors working through reputable brokers and adhering to disclosure requirements face minimal compliance risk, as brokers typically handle regulatory obligations on their clients’ behalf.

When evaluating which publicly traded Israeli companies offer the best opportunities, investors should understand TASE’s sector composition and the leading companies within each industry. Israel’s economy has distinct strengths that translate into compelling investment themes.

The technology sector represents TASE’s crown jewel, accounting for approximately 45% of total market capitalization in 2026. Israel’s reputation as the ‘Startup Nation’ stems from its exceptional concentration of tech companies, many of which eventually list on TASE or dual-list on both TASE and NASDAQ.

Nice Ltd (NICE), a leader in cloud and on-premise enterprise software, exemplifies the quality of Israeli tech companies. With market capitalization exceeding $12 billion, NICE provides analytics solutions for customer engagement and financial crime prevention to organizations worldwide. The company’s consistent revenue growth and strong margins make it a core holding for many TASE-focused portfolios.

Check Point Software Technologies (CHKP) pioneered the cybersecurity industry and remains a dominant force with its comprehensive security solutions. Trading on both NASDAQ and TASE, Check Point demonstrates the dual-listing phenomenon common among Israeli tech giants. Its strong free cash flow generation and regular dividend payments appeal to both growth and income investors.

Wix.com (WIX), the website building platform, represents Israel’s success in consumer-facing technology. Despite intense competition from international players, Wix has built a sustainable business model with millions of subscribers globally, showcasing Israeli companies’ ability to scale globally from a small domestic market.

Beyond these established leaders, TASE hosts numerous mid-cap technology companies specializing in artificial intelligence, autonomous vehicles, fintech, and enterprise software. These smaller publicly traded stock companies often offer higher growth potential alongside increased volatility.

Israel’s pharmaceutical and biotechnology sector ranks second in TASE importance, representing roughly 20% of market capitalization. The country’s strong academic research institutions, government support for life sciences, and culture of innovation have created a vibrant biotech ecosystem.

Teva Pharmaceutical Industries (TEVA) stands as Israel’s largest company by revenue and a global leader in generic pharmaceuticals. Despite facing challenges in recent years from pricing pressure and patent expirations, Teva’s restructuring efforts and pipeline development make it a turnaround candidate that some value investors find compelling. The company’s dual listing on both TASE and the New York Stock Exchange provides liquidity and international visibility.

Oramed Pharmaceuticals represents the innovative biotechnology segment, developing oral drug delivery systems for medications traditionally administered by injection. Small-cap biotech companies like Oramed offer significant upside potential if clinical trials succeed, though they carry substantial risk for investors unfamiliar with the sector’s dynamics.

Kamada Ltd specializes in plasma-derived protein therapeutics, operating in a niche but stable market segment. Such mid-cap pharmaceutical companies often provide a balance between the growth potential of early-stage biotech and the stability of established pharmaceutical giants.

The Israeli government’s support for life sciences research, including grants from the Israel Innovation Authority and collaborations between academic institutions and industry, continues to fuel the pipeline of publicly traded stock companies in this sector.

Israel’s financial sector, while less globally prominent than technology, provides essential diversification for TASE portfolios and represents approximately 15% of market capitalization. The sector includes major banks, insurance companies, and specialized financial services providers.

Bank Hapoalim and Bank Leumi, Israel’s two largest banks, dominate the banking landscape. These institutions offer exposure to Israel’s domestic economic growth while providing stable dividend yields. Regulatory reforms in recent years have increased competition and operational efficiency, potentially improving shareholder returns.

Migdal Insurance and The Phoenix Holdings represent the insurance segment, offering products ranging from life insurance to pension management. Israel’s mandatory pension system creates steady demand for these services, providing revenue stability even during economic downturns.

The financial sector’s performance correlates strongly with Israeli economic conditions, interest rate policies from the Bank of Israel, and real estate market dynamics. For foreign investors, these companies provide a way to gain broad exposure to Israel’s economic growth beyond the technology sector’s specific dynamics.

While less prominent than technology and pharmaceuticals, TASE’s industrial and real estate sectors offer additional diversification opportunities. Companies like Israel Chemicals (ICL), a global specialty minerals and chemicals company, provide exposure to commodity cycles and agricultural trends.

The real estate sector includes both operating companies and Real Estate Investment Trusts (REITs) focused on Israeli commercial and residential properties. For foreign investors seeking income, some of these companies offer attractive dividend yields backed by tangible assets, though they require understanding of local property market dynamics.

The stock exchange IPO market on TASE offers foreign investors opportunities to participate in emerging Israeli companies going public. Understanding the IPO process, typical pricing dynamics, and access mechanisms helps investors evaluate whether IPO participation aligns with their investment strategy.

TASE averages 15-25 IPOs annually, with significant year-to-year variation depending on market conditions, economic climate, and company readiness. The 2026 IPO pipeline includes technology companies seeking capital for expansion, real estate projects requiring public funding, and established private companies transitioning to public ownership for liquidity or succession planning.

The IPO process on TASE follows a structured timeline beginning with ISA registration and prospectus filing. Companies must disclose comprehensive financial information, risk factors, use of proceeds, and governance structures. The prospectus review period typically spans 30-60 days, during which the ISA may request additional information or clarifications.

Pricing mechanisms vary, with most IPOs using a bookbuilding process where institutional and retail investors submit orders at various price levels, allowing underwriters to gauge demand and set the final offering price. Some smaller offerings use fixed-price methods where the price is predetermined before the offering period begins.

Foreign investors can participate in TASE IPOs through their brokers, though access levels vary. International brokers with TASE connections may offer IPO access to clients, while Israeli brokerage firms typically provide more comprehensive IPO participation opportunities. However, IPO allocations often prioritize institutional investors and local retail clients, potentially limiting foreign retail investor access to the most sought-after offerings.

Dual-listing represents a unique aspect of the Israeli IPO landscape. Many companies, particularly in technology, choose to list initially on NASDAQ or the New York Stock Exchange and subsequently add a TASE listing. Conversely, some successful TASE companies later pursue international listings to access deeper capital pools and increase global visibility. These dual-listed companies trade on both public stock exchanges simultaneously, with arbitrage mechanisms generally keeping prices aligned across markets after accounting for currency fluctuations.

Historical IPO performance on TASE shows mixed results, with technology companies generally outperforming while real estate and financial IPOs demonstrate more modest returns. First-day ‘pops’ are less dramatic than on some international exchanges, averaging 5-8% for successful offerings, though exceptional deals occasionally generate larger initial gains.

The lock-up period, during which insiders and pre-IPO investors cannot sell shares, typically lasts 90-180 days. Foreign investors should monitor lock-up expiration dates, as significant insider selling can pressure share prices in the months following expiration.

Due diligence for IPO investments requires careful prospectus analysis, understanding of the company’s competitive position, assessment of growth prospects, and valuation comparison with similar publicly traded stock companies already on TASE or international exchanges. Many foreign investors prefer waiting several quarters after an IPO to evaluate actual public company performance before investing.

Tax considerations significantly impact net returns for foreign investors in TASE-listed securities. Understanding the tax treatment of dividends and capital gains for non-resident investors enables accurate return projections and proper tax planning.

Israeli withholding tax on dividends paid to non-residents stands at 25% under domestic law. However, Israel has signed tax treaties with over 60 countries that often reduce this rate to 15% or even lower in some cases. Foreign investors should verify whether their country of tax residence has a treaty with Israel and ensure their broker applies the reduced treaty rate.

To benefit from reduced treaty rates, investors must complete Israeli tax forms (typically Form 2402 or its equivalent) and provide documentation of tax residency in a treaty country. Most brokers facilitate this process, but investors bear responsibility for ensuring proper documentation is filed. Without appropriate forms, brokers must withhold at the standard 25% rate.

The dividend withholding tax is generally final for non-residents, meaning Israel considers the tax obligation satisfied through withholding, and investors need not file Israeli tax returns solely for dividend income. However, investors should report these dividends in their home country and may be able to claim foreign tax credits to avoid double taxation.

Capital gains taxation for non-resident investors follows different rules. Israeli tax law generally exempts non-residents from capital gains tax on sales of publicly traded stock companies listed on TASE, provided the shares were purchased on the stock exchange (rather than in a private transaction) and the investor does not hold 10% or more of the company.

This capital gains exemption represents a significant advantage for foreign portfolio investors compared to some other markets. However, several exceptions apply. If a non-resident investor holds 10% or more of a company’s shares or voting rights at any point during the 12 months preceding the sale, capital gains may be subject to Israeli taxation at rates ranging from 25-30%.

Additionally, if shares were acquired through means other than stock exchange purchases (such as private placements, employee compensation, or conversion of convertible securities), different tax treatment may apply. Investors should consult tax professionals when dealing with complex acquisition methods.

Real estate companies present special considerations. Israeli tax law includes provisions that may impose capital gains tax on sales of ‘land-rich companies’ even for non-resident portfolio investors, though implementation details and thresholds continue to evolve.

Currency gains and losses add another layer of complexity. When Israeli stocks are purchased and sold in New Israeli Shekels but the investor’s home currency differs, exchange rate fluctuations create currency gains or losses separate from the underlying security’s performance. Home country tax authorities may tax these currency effects even when Israeli capital gains are exempt.

U.S. investors face additional reporting requirements under FATCA (Foreign Account Tax Compliance Act) and must report foreign financial accounts exceeding certain thresholds on Form 8938 and FBAR. Other countries have implemented similar reporting regimes that may apply to TASE holdings.

Estate and inheritance taxes represent another consideration for long-term investors. Israel does not impose estate tax on publicly traded securities held by non-residents, but investors’ home countries may include foreign securities in taxable estates.

Tax efficiency strategies for TASE investors include holding Israeli stocks in tax-advantaged accounts where permitted, timing capital gains realizations to optimize home country tax treatment, and utilizing tax-loss harvesting when positions decline in value. However, account type eligibility varies by jurisdiction, with some countries restricting foreign securities in retirement accounts.

Given the complexity of cross-border taxation, foreign investors should consult qualified tax advisors familiar with both Israeli tax law and their home country’s treatment of foreign investment income. Proper tax planning can significantly enhance after-tax returns from publicly traded stock companies on TASE.

While TASE offers compelling opportunities, foreign investors must understand and evaluate several risk factors unique to investing in Israeli publicly traded stock companies.

Geopolitical risk stands as the most obvious concern for foreign investors considering TASE. Israel’s location in a volatile region and ongoing regional tensions create periodic security events that can impact market sentiment. Historically, TASE has demonstrated resilience, often recovering quickly from geopolitical incidents, but short-term volatility can be significant. Investors must assess their tolerance for these geopolitical uncertainties and potentially size positions accordingly.

Currency risk affects all foreign investors in TASE securities. The New Israeli Shekel’s value against major currencies fluctuates based on economic conditions, interest rate differentials, energy prices, and geopolitical factors. Currency movements can enhance or diminish returns when converted back to an investor’s home currency. Some investors hedge currency exposure through forward contracts or currency ETFs, while others view currency as part of the total return opportunity.

Market liquidity varies significantly across TASE-listed securities. While the largest companies in the TA-35 Index offer robust liquidity comparable to mid-cap stocks on major international exchanges, smaller publicly traded stock companies may have limited trading volumes. Low liquidity can result in wide bid-ask spreads, difficulty executing large orders without moving prices, and potential challenges exiting positions during market stress.

Information accessibility poses challenges for foreign investors who don’t read Hebrew. While major companies provide English financial reports and presentations, regulatory filings, corporate governance documents, and detailed footnotes often appear only in Hebrew. This language barrier can leave foreign investors at an informational disadvantage compared to local investors.

Corporate governance standards on TASE have improved significantly but may differ from expectations in some developed markets. Concentrated ownership structures, where founding families or controlling shareholders maintain significant influence, are common among Israeli companies. While this can align management with long-term value creation, it may also limit minority shareholder influence and create potential conflicts of interest.

Regulatory differences between Israel and investors’ home markets require adjustment. Disclosure timing, materiality thresholds, and corporate action procedures may differ from familiar patterns, potentially creating confusion or delayed awareness of important developments.

Economic concentration risk stems from Israel’s relatively small economy and market. TASE’s heavy weighting toward technology and pharmaceuticals means sector-specific downturns can impact the overall market more severely than in more diversified economies. Additionally, Israeli economic policies, particularly regarding the technology sector and defense industries, can significantly influence company performance.

Time zone differences create practical challenges for active traders. TASE operates during Israeli business hours, which overlap partially with European markets but occur during nighttime hours for American investors on the East Coast and early morning for West Coast investors. This timing can make real-time trading and monitoring more difficult for investors in certain locations.

Constructing an effective portfolio of publicly traded stock companies on TASE requires strategic thinking about diversification, position sizing, and alignment with overall investment objectives.

Sector diversification remains crucial despite technology’s dominance. While Israeli tech companies offer compelling growth prospects, concentrating entirely in this sector exposes investors to technology-specific risks and valuation cycles. A balanced approach might allocate 40-50% to technology, 20-25% to pharmaceuticals, 15-20% to financials, and the remainder to industrial and consumer companies, adjusted based on individual risk tolerance and market outlook.

Market capitalization diversification provides another dimension. Large-cap companies like Teva, Check Point, and Bank Hapoalim offer stability and liquidity, while mid-cap and small-cap stocks provide higher growth potential alongside increased volatility. A core portfolio of large-cap holdings supplemented with selective mid-cap positions often balances these considerations effectively.

International investors should consider how TASE holdings fit within their global portfolio. For investors already holding U.S.-listed Israeli companies like Wix or Monday.com, adding their TASE-listed peers creates concentrated exposure to Israeli economic and geopolitical factors. Conversely, investors with limited emerging market exposure might view TASE as an attractive entry point into a developed but high-growth economy.

Dual-listed companies present strategic choices. When a company trades on both TASE and an international exchange, investors can choose their preferred venue based on liquidity needs, trading hour preferences, and currency considerations. Generally, trading in the more liquid venue (often the international listing for large tech companies) provides tighter spreads, though TASE trading may offer advantages during Israeli market hours.

Dividend-focused investors can construct income portfolios from TASE’s financial services companies, mature technology firms, and select industrial companies. Israeli dividend yields generally range from 2-4% for stable dividend payers, competitive with developed market alternatives while offering growth potential from Israeli economic expansion.

Rebalancing discipline becomes particularly important given Israeli market volatility. Setting predetermined thresholds (such as rebalancing when allocations drift more than 5% from targets) helps maintain desired risk exposure and systematically implements buy-low, sell-high principles.

Currency hedging decisions should align with investment time horizons and views on shekel strength. Long-term investors often leave currency exposure unhedged, viewing it as part of total return, while shorter-term investors might hedge to isolate security selection returns from currency movements.

Research resources available to foreign investors include company investor relations websites, which often provide English materials; Israeli financial media outlets like Globes and The Jerusalem Post, which publish English editions; international investment research platforms; and broker-provided research reports. Building a comprehensive information network helps compensate for the language and distance challenges.

Position sizing should reflect both conviction levels and liquidity considerations. For less liquid small-cap stocks, limiting positions to 2-3% of portfolio value helps ensure exit flexibility, while large-cap holdings might reasonably constitute 5-7% or more for high-conviction ideas.